Breaking News
Get 55% Off 0
🎈 Up Big Today: Find today's biggest gainers with our free screener
Try Stock Screener
Close

Novo Nordisk A/S Class B (0QIU)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
759.05 -30.20    -3.83%
13/12 - Closed. Currency in DKK
Type:  Equity
Market:  United Kingdom
ISIN:  DK0060534915 
SEDOL:  BP6KMR9
  • Volume: 1,296,367
  • Bid/Ask: 784.00 / 816.00
  • Day's Range: 741.00 - 785.40
Novo Nordisk B 759.05 -30.20 -3.83%

0QIU Recent Sentiments

 
This page features our user's sentiments regarding the Novo Nordisk A/S Class B share. They are displayed on both charts of different time periods and in a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Dec 09, 2024 Muhamad Amin Adnani   789.40 -3.84%
Oct 11, 2024 suayip Teke   801.70 Nov 01, 2024 @ 767.55 +4.26%
May 07, 2024 且珍惜 且行   866.30 May 31, 2024 @ 928.75 +7.21%
May 07, 2024 Stephen Healy   860.80 May 31, 2024 @ 928.75 +7.89%
Apr 30, 2024 shaukat sultan   910.50 May 24, 2024 @ 937.40 +2.95%
Mar 20, 2024 Necdet Alper   899.60 Apr 12, 2024 @ 887.40 +1.36%
Feb 13, 2024 且珍惜 且行   831.90 Mar 08, 2024 @ 910.00 +9.39%
Nov 24, 2023 Daniel Yordanov   711.20 Nov 30, 2023 @ 683.95 -3.83%
Nov 13, 2023 Ochu Faheem   685.10 Dec 08, 2023 @ 666.60 -2.70%
Sep 28, 2023 Ярослав Рябинин   649.40 Nov 30, 2023 @ 683.95 +5.32%
Sep 06, 2023 TJ POPOOLA   332.30 Nov 30, 2023 @ 683.95 +105.82%
Aug 30, 2023 saroj rout   322.85 Nov 30, 2023 @ 683.95 +111.85%
Aug 21, 2023 PANKAJ PATEL   317.25 Nov 30, 2023 @ 683.95 +115.59%
Jun 30, 2023 ADRIAN EVES   268.05 Nov 30, 2023 @ 683.95 +155.16%
Mar 31, 2023 Lilia Litvin   1082.00 Apr 21, 2023 @ 1155.90 -6.83%
Feb 28, 2023 PANKAJ PATEL   998.60 Mar 24, 2023 @ 1044.60 +4.61%
Jan 10, 2023 Asma Abd   930.00 Jan 10, 2023 @ 930.00 0.00%
Jan 10, 2023 Asma Abd   930.00 Jan 10, 2023 @ 930.00 0.00%
Dec 21, 2022 PANKAJ PATEL   923.90 Jan 13, 2023 @ 932.75 -0.96%
Dec 05, 2022 Adam Mohamed   893.10 Dec 30, 2022 @ 938.55 +5.09%
May 30, 2022 Graham Patton   773.50 Jun 24, 2022 @ 778.95 +0.70%
Sep 20, 2021 Zeev Goldberg   629.70 Oct 15, 2021 @ 653.15 +3.72%
Aug 31, 2021 Rachel Cohen   629.70 Sep 24, 2021 @ 633.35 +0.58%
Aug 10, 2021 Gail Baglow   640.80 Sep 03, 2021 @ 633.95 -1.07%
Jul 20, 2021 Rachel Cohen   551.90 Aug 13, 2021 @ 643.65 +16.62%
Feb 26, 2021 John Monteiro   443.10 Feb 27, 2021 @ 443.10 0.00%
Jan 11, 2021 Karun Pudasaini   431.72 Feb 05, 2021 @ 444.77 +3.02%
Jul 03, 2020 Becky Steyn   439.60 Jul 24, 2020 @ 428.20 -2.59%
Oct 30, 2019 Foyin Olufemi   370.20 Nov 22, 2019 @ 369.73 -0.13%
Aug 29, 2019 Nesa Marley   355.35 Sep 20, 2019 @ 357.43 +0.59%
Aug 06, 2019 ziya yılmaz   321.70 Aug 22, 2019 @ 353.90 +10.01%
Aug 05, 2019 ziya yılmaz   324.30 Aug 06, 2019 @ 321.70 -0.80%
Aug 01, 2019 ziya yılmaz   329.25 Aug 05, 2019 @ 324.30 -1.50%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NOVOb Comments

Write your thoughts about Novo Nordisk L
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email